Economic Burden of Sanfilippo Syndrome in the United States

por Ashby, Frederick, Park, Haesuk, Svensson, Mikael, Heldermon, Coy D.
Publicado 2023

Mucopolysaccharidosis type IIIB: a current review and exploration of the AAV therapy landscape

por Rouse, Courtney J., Jensen, Victoria N., Heldermon, Coy D.
Publicado 2023

Patient out-of-pocket and payer costs for pegfilgrastim originator vs biosimilars as primary prophylaxis of febrile neutropenia in the first cycle among a commercially insured popu...

por Wang, Ching-Yu, Park, Haesuk, Heldermon, Coy D, Vouri, Scott M, Brown, Joshua D
Publicado 2022

Comparative effectiveness of pegfilgrastim biosimilars vs originator for prevention of febrile neutropenia: A retrospective cohort study

por Wang, Ching-Yu, Vouri, Scott M, Park, Haesuk, Heldermon, Coy D, Brown, Joshua D
Publicado 2023

Epidemiological, Clinical, and Histopathological Features of Breast Cancer in Haiti

por DeGennaro, Vincent, Jiwani, Faiz, Patberg, Elizabeth, Gibbs, Martin, Libby, Rachel, Gabriel, Dieudina, Heldermon, Coy D., Daily, Karen, Bernard, Joseph
Publicado 2018

Sex differences in brain transcriptomes of juvenile Cynomolgus macaques

por Kabbej, Nadia, Ashby, Frederick J., Riva, Alberto, Gamlin, Paul D., Mandel, Ronald J., Kunta, Aishwarya, Rouse, Courtney J., Heldermon, Coy D.
Publicado 2023

Differential expression and function of CAIX and CAXII in breast cancer: A comparison between tumorgraft models and cells

por Chen, Zhijuan, Ai, Lingbao, Mboge, Mam Y., Tu, Chingkuang, McKenna, Robert, Brown, Kevin D., Heldermon, Coy D., Frost, Susan C.
Publicado 2018

The beta-glucuronidase intracisternal A particle insertion model results in similar overall MPSVII phenotype as the single base deletion model when on the same C57BL/6J mouse backg...

por Devanney, Sean C., Gibney, Joseph M., Le Prell, Colleen G., Wronski, Thomas J., Aguirre, J.I., Mcdoom, Issam, Heldermon, Coy D.
Publicado 2021

Trends, characteristics, race, and ethnicity associated with nonadherence to antidepressants among breast cancer survivors with depression

por Chang, Ching-Yuan, Park, Haesuk, Hincapie-Castillo, Juan M, Heldermon, Coy D, Diaby, Vakaramoko, Yang, Seonkyeong, Wilson, Debbie L, Lo-Ciganic, Wei-Hsuan
Publicado 2023

Site-specific modifications to AAV8 capsid yields enhanced brain transduction in the neonatal MPS IIIB mouse

por Gilkes, Janine A., Judkins, Benjamin L., Herrera, Brontie N., Mandel, Ronald J., Boye, Sanford L., Boye, Shannon E., Srivastava, Arun, Heldermon, Coy D.
Publicado 2020

Trends in Use of Granulocyte Colony-Stimulating Factor Following Introduction of Biosimilars Among Adults With Cancer and Commercial or Medicare Insurance From 2014 to 2019

por Wang, Ching-Yu, Heldermon, Coy D., Vouri, Scott M., Park, Haesuk, Wheeler, Sarah E., Ramnaraign, Brian Hemendra, Dang, Nam Hoang, Brown, Joshua D.
Publicado 2021

Development of Sensory, Motor and Behavioral Deficits in the Murine Model of Sanfilippo Syndrome Type B

por Heldermon, Coy D., Hennig, Anne K., Ohlemiller, Kevin K., Ogilvie, Judith M., Herzog, Erik D., Breidenbach, Annalisa, Vogler, Carole, Wozniak, David F., Sands, Mark S.
Publicado 2007

Femoral Structure and Biomechanical Characteristics in Sanfilippo Syndrome Type-B Mice

por Ashby, Frederick James, Castillo, Evelyn J., Ludwig, Yan, Andraka, Natalia K., Chen, Cong, Jamieson, Julia C., Kabbej, Nadia, Sommerville, John D., Aguirre, Jose I., Heldermon, Coy D.
Publicado 2023

Disease correction by combined neonatal intracranial AAV and systemic lentiviral gene therapy in Sanfilippo Syndrome type B mice

por Heldermon, Coy D., Qin, Elizabeth Y., Ohlemiller, Kevin K., Herzog, Erik D., Brown, Jillian R., Vogler, Carol, Hou, Wei, Orrock, John L., Crawford, Brett E., Sands, Mark S.
Publicado 2013

Repurposing Tranexamic Acid as an Anticancer Agent

por Law, Mary E., Davis, Bradley J., Ghilardi, Amanda F., Yaaghubi, Elham, Dulloo, Zaafir M., Wang, Mengxiong, Guryanova, Olga A., Heldermon, Coy D., Jahn, Stephan C., Castellano, Ronald K., Law, Brian K.
Publicado 2022

Obesity and STING1 genotype associate with 23-valent pneumococcal vaccination efficacy

por Sebastian, Mathew, Hsiao, Chu J., Futch, Hunter S., Eisinger, Robert S., Dumeny, Leanne, Patel, Seema, Gobena, Mesfin, Katikaneni, Divya S., Cohen, Joel, Carpenter, Anne-Marie, Spiryda, Lisa, Heldermon, Coy D., Jin, Lei, Brantly, Mark L.
Publicado 2020

Disulfide bond disrupting agents activate the unfolded protein response in EGFR- and HER2-positive breast tumor cells

por Ferreira, Renan B., Wang, Mengxiong, Law, Mary E., Davis, Bradley J., Bartley, Ashton N., Higgins, Paul J., Kilberg, Michael S., Santostefano, Katherine E., Terada, Naohiro, Heldermon, Coy D., Castellano, Ronald K., Law, Brian K.
Publicado 2017

Disulfide bond-disrupting agents activate the tumor necrosis family-related apoptosis-inducing ligand/death receptor 5 pathway

por Wang, Mengxiong, Law, Mary E., Davis, Bradley J., Yaaghubi, Elham, Ghilardi, Amanda F., Ferreira, Renan B., Chiang, Chi-Wu, Guryanova, Olga A., Kopinke, Daniel, Heldermon, Coy D., Castellano, Ronald K., Law, Brian K.
Publicado 2019